IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v43y2020i3d10.1007_s40264-019-00885-4.html
   My bibliography  Save this article

Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008–2013

Author

Listed:
  • John S. Fountain

    (Best Practice Advocacy Centre New Zealand
    University of Otago)

  • Andrew M. Tomlin

    (Best Practice Advocacy Centre New Zealand)

  • David M. Reith

    (University of Otago)

  • Murray W. Tilyard

    (Best Practice Advocacy Centre New Zealand
    University of Otago)

Abstract

Introduction The fatal toxicity index (FTI) is a measure for assessing the relative risks of death due to the medicines prescribed in a population. This knowledge is useful for prescribers and informs medicine safety initiatives. This study aimed to calculate FTIs for the New Zealand population using three methodologies. Methods New Zealand coronial data describing medicine-related deaths from 1 January 2008 to 31 December 2013 were retrospectively extracted from the National Coronial Information System. Three fatal toxicity indices were derived using the number of deaths attributed to each pharmaceutical as the numerator and the total defined daily doses, number of patients and number of prescriptions as denominators. Results There were 703 medicine-related deaths, of which 627 were assessed as due to one primary contributor. Median decedent age was 48 years (interquartile range 37–58), and 319 (51%) were male. Deaths were intentional in 252 cases (40%), unintentional in 284 (45%) and unknown in 91 (15%). The majority of deaths (n = 486, 78%) occurred in the community. Opioids, antidepressants, antipsychotics and hypnotic-anxiolytics caused most fatalities. While the FTIs for individual medicines varied by denominator applied, methadone and clozapine fatalities were prominent in all three indices. The antidepressants clomipramine, dosulepin and doxepin consistently returned the highest FTIs in their group. Conclusion New Zealand prescribers should be aware of the high relative risk of death associated with methadone and clozapine; that clomipramine, dosulepin and doxepin were identified as the most dangerous antidepressants; and that zopiclone carries a similar fatal risk to benzodiazepines. Varying results were found between the FTIs calculated, making comparisons, particularly between populations, difficult.

Suggested Citation

  • John S. Fountain & Andrew M. Tomlin & David M. Reith & Murray W. Tilyard, 2020. "Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008–2013," Drug Safety, Springer, vol. 43(3), pages 223-232, March.
    • Handle: RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00885-4
    DOI: 10.1007/s40264-019-00885-4
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-019-00885-4
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-019-00885-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Robin E. Ferner & Craig Easton & Anthony R. Cox, 2018. "Deaths from Medicines: A Systematic Analysis of Coroners’ Reports to Prevent Future Deaths," Drug Safety, Springer, vol. 41(1), pages 103-110, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Robin E. Ferner & Tohfa Ahmad & Zainab Babatunde & Anthony R. Cox, 2019. "Preventing Future Deaths from Medicines: Responses to Coroners’ Concerns in England and Wales," Drug Safety, Springer, vol. 42(3), pages 445-451, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00885-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.